Abstract | BACKGROUND: Since margin-negative resection is essential for the cure of pancreatic cancer (PC), early detection of PC is important. Although PC is the third most common cancer associated with BRCA1/2 mutations, clinical research regarding BRCA mutations in resected PC are rare. In this study, we investigated the oncologic characteristics of resected PC with BRCA mutation to suggest management strategies. METHODS: We retrospectively reviewed data from 493 patients who were confirmed to be pathogenic BRCA1/2 mutation carriers between January 2007 and December 2019. We investigated the oncologic characteristics of PC patients by comparing them with resected sporadic PC and other BRCA-related cancer groups (breast cancer, ovarian cancer, and others). RESULTS: Ten BRCA mutation carriers (2.0%) experienced PC, and PC onset was significantly later than that of BRCA-related breast cancer (age: breast vs. pancreas, 45.0 vs. 53.5 years, p = 0.050). Six patients underwent pancreatectomy and their long-term survival outcomes did not differ from those of sporadic PC patients (disease free survival: BRCA1/2 vs. sporadic, 10.0 months vs. 9.0 months, p = 0.504; overall survival: BRCA1/2 vs. sporadic, 29.0 months vs. 35.0 months, p = 0.520). CONCLUSION: BRCA-mutated PC occurs later than BRCA-mutated breast cancer. Active genetic testing to identify BRCA1/2 mutation carriers at the onset of breast cancer and continuous long-term surveillance of these patients can provide opportunities to detect BRCA-mutated PC at a resectable stage.
|
Authors | Sung Hyun Kim, Ho Kyoung Hwang, Woo Jung Lee, Chang Moo Kang |
Journal | Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
(Pancreatology)
Vol. 21
Issue 3
Pg. 544-549
(Apr 2021)
ISSN: 1424-3911 [Electronic] Switzerland |
PMID | 33612442
(Publication Type: Journal Article)
|
Copyright | Copyright © 2021 IAP and EPC. Published by Elsevier B.V. All rights reserved. |
Chemical References |
- BRCA1 Protein
- BRCA1 protein, human
- BRCA2 Protein
- BRCA2 protein, human
- Biomarkers, Tumor
|
Topics |
- Adult
- Aged
- BRCA1 Protein
(genetics)
- BRCA2 Protein
(genetics)
- Biomarkers, Tumor
(genetics)
- Breast Neoplasms
(diagnosis, genetics)
- Case-Control Studies
- Early Detection of Cancer
(methods)
- Female
- Follow-Up Studies
- Genetic Testing
- Humans
- Male
- Middle Aged
- Ovarian Neoplasms
(diagnosis, genetics)
- Pancreatectomy
- Pancreatic Neoplasms
(diagnosis, genetics, mortality, surgery)
- Retrospective Studies
- Survival Analysis
- Treatment Outcome
|